Literature DB >> 17362763

Ischemia-reperfusion injury: processes in pathogenetic networks: a review.

H de Groot1, U Rauen.   

Abstract

Ischemia-reperfusion injury is a complex phenomenon involving not only intracellular injury processes but also an injurious inflammatory response. Both the intracellular injury processes and the injurious events of the inflammatory response are interconnected in pathogenetic networks. Anoxic cell injury predominates in the ischemic phase. The decreased mitochondrial ATP generation impairs cellular ion homeostasis with activation of hydrolases and loss of selective permeability of cell membranes. Upon resupply of blood, the inflammatory response is initiated. Resident cells of the affected tissue, blood-derived cells, and noncellular elements such as the complement system are activated, and signalling and other molecules are formed at altered rates. Cell injury occurring in the reperfusion phase may either be a consequence of cellular alterations that were already initiated in the ischemic phase or may result from the inflammatory response. The intracellular injurious alterations are in part the same as those involved in anoxic cell injury. In addition, activation of intracellular signalling cascades and of apoptotic pathways may take place. Except for a large decrease in their rates, no significant difference exists between the injury processes during warm and cold ischemia as they become evident during ischemia itself. In contrast, the injury processes of the inflammatory response and of cell injury in the reperfusion phase significantly vary depending on pre-existent warm versus cold ischemia. Because of the netlike characteristics of the pathomechanisms, a multifactorial approach is required to provide protection against ischemia-reperfusion injury.

Entities:  

Mesh:

Year:  2007        PMID: 17362763     DOI: 10.1016/j.transproceed.2006.12.012

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  75 in total

1.  Conditioned medium from hypoxic cells protects cardiomyocytes against ischemia.

Authors:  B Chanyshev; A Shainberg; A Isak; Y Chepurko; E Porat; E Hochhauser
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

Review 2.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

3.  Enhancing complement control on endothelial barrier reduces renal post-ischemia dysfunction.

Authors:  Sathnur B Pushpakumar; Gustavo Perez-Abadia; Chirag Soni; Rong Wan; Nathan Todnem; Phani K Patibandla; Tathyana Fensterer; Qunwei Zhang; John H Barker; Claudio Maldonado
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

Review 4.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

5.  The role of neutrophil extracellular traps and TLR signaling in skeletal muscle ischemia reperfusion injury.

Authors:  Nicole J Edwards; Charles Hwang; Simone Marini; Chase A Pagani; Philip J Spreadborough; Cassie J Rowe; Pauline Yu; Annie Mei; Noelle Visser; Shuli Li; Geoffrey E Hespe; Amanda K Huber; Amy L Strong; Miriam A Shelef; Jason S Knight; Thomas A Davis; Benjamin Levi
Journal:  FASEB J       Date:  2020-10-22       Impact factor: 5.191

6.  Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome.

Authors:  E Madison Sullivan; Edward Ross Pennington; Genevieve C Sparagna; Maria J Torres; P Darrell Neufer; Mitchel Harris; James Washington; Ethan J Anderson; Tonya N Zeczycki; David A Brown; Saame Raza Shaikh
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

Review 7.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

Review 8.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

9.  Enterocyte shedding and epithelial lining repair following ischemia of the human small intestine attenuate inflammation.

Authors:  Robert A Matthijsen; Joep P M Derikx; Dian Kuipers; Ronald M van Dam; Cornelis H C Dejong; Wim A Buurman
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

10.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.